✳ ORIONCLINICAL BUSINESS RESEARCH
← Business-development research

PUBLIC SAMPLE / 001 · CHECKED 11 SEP 2026 UTC

A relevant trial.
Not yet a qualified lead.

STOP-HAE · ADARx Pharmaceuticals, Inc.

This real registry snapshot demonstrates the screening format. The CRO profile below is hypothetical. ADARx is not an ORION customer and no relationship is implied.

01 / WHAT THE RECORD SAYS

Trace every fact.

Trial
NCT06960213 · STOP-HAE
Lead sponsor
ADARx Pharmaceuticals, Inc.
Condition / phase
Hereditary angioedema / Phase 3
Overall status
Recruiting
Enrollment
90 participants · estimated
Primary completion
30 Nov 2027 · estimated
Last update posted
10 Sep 2026

Snapshot checked 2026-09-11T21:42:16.673Z. Estimated completion is not a promised results-release date. No previous version was compared, so this brief makes no claim about what changed.

03 / THE QUESTIONS THAT MATTER NEXT

Qualify before outreach.

01

Existing relationships

Which vendors are already appointed? Is any relevant work unassigned? This snapshot does not answer either question.

02

Service and geography

Does the sponsor's actual operating scope overlap with the CRO's capabilities, experience and locations?

03

Timing and evidence

Is there current, independent evidence of a procurement need? A registry update alone is insufficient.

APPLY THIS PROCESS TO YOUR NICHE

Your services.
Your research question.

Would this help your team decide whom to research next? Tell us what is relevant, already known or missing from this example. We can first check your scope; the $500 one-time pilot is a separate next step.

Discuss your scope ↗